Medtronic plc
MDT · NYSE
10/24/2025 | 7/25/2025 | 4/30/2025 | 1/24/2025 | |
|---|---|---|---|---|
| Revenue | $8,961 | $8,578 | $8,927 | $8,292 |
| % Growth | 4.5% | -3.9% | 7.7% | – |
| Cost of Goods Sold | $3,556 | $3,632 | $3,147 | $2,779 |
| Gross Profit | $5,405 | $4,946 | $5,780 | $5,513 |
| % Margin | 60.3% | 57.7% | 64.7% | 66.5% |
| R&D Expenses | $754 | $726 | $684 | $675 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,966 | $2,806 | $2,720 | $2,717 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$31 | $940 | $475 |
| Operating Expenses | $3,720 | $3,501 | $4,344 | $3,867 |
| Operating Income | $1,685 | $1,445 | $1,436 | $1,646 |
| % Margin | 18.8% | 16.8% | 16.1% | 19.9% |
| Other Income/Exp. Net | -$89 | -$143 | -$175 | -$106 |
| Pre-Tax Income | $1,596 | $1,302 | $1,261 | $1,540 |
| Tax Expense | $215 | $255 | $199 | $237 |
| Net Income | $1,374 | $1,040 | $1,057 | $1,294 |
| % Margin | 15.3% | 12.1% | 11.8% | 15.6% |
| EPS | 1.07 | 0.81 | 0.82 | 1.01 |
| % Growth | 32.1% | -1.2% | -18.8% | – |
| EPS Diluted | 1.07 | 0.81 | 0.82 | 1.01 |
| Weighted Avg Shares Out | 1,282 | 1,282 | 1,282 | 1,282 |
| Weighted Avg Shares Out Dil | 1,288 | 1,287 | 1,288 | 1,286 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $33 | $0 | $0 |
| Interest Expense | $181 | $176 | $174 | $179 |
| Depreciation & Amortization | $589 | $748 | $840 | $684 |
| EBITDA | $2,366 | $2,225 | $2,275 | $2,403 |
| % Margin | 26.4% | 25.9% | 25.5% | 29% |